Skip to main content
. 2020 Oct 28;21(21):8018. doi: 10.3390/ijms21218018

Figure 2.

Figure 2

Pharmacological inhibitors targeting the Wnt pathway that are currently being tested for cancer treatment. Representation of pharmaceutical compounds that disrupt the Wnt pathway at several stages, including the Wnt-receptor complex, β-catenin destruction complex, and TCF/β-catenin transcriptional complex.